Archeon, a Besançon, France-based CPR artificial intelligence company, closed a €5.5 million in Series A financing.
The round was led by Karot Capital, Majycc eSanté Invest and Daphni, supported by the European Regional Development Fund (ERDF – European Social Fund for Franche-Comté and Massif du Jura), and by Bpifrance.
The company intends to use the funds to access new markets including North America, to expand its range of medical ventilation devices to new pre-hospital and hospital uses, and expand its current team of 17 people by creating R&D and marketing jobs.
Round: Series A
Funding Month: March 2022
Lead Investors: Karot Capital, Majycc eSanté Invest and Daphni
Additional Investors: European Regional Development Fund and Bpifrance
Company Website: https://www.archeon-medical.com/
Software Category: AI-powered ventilation
About the Company: Created in January 2018 by Alban De Luca and Pierre-Edouard Saillard, Archeon designed EOlife, a device to assist manual ventilation in cases of cardiorespiratory arrest. The system automatically measures and analyses the patient’s respiratory variables in real-time, to deliver enough oxygen while avoiding hyperventilation. It is marketed directly and via a distribution network in France and around the world since the beginning of 2020. In addition to the EOlife unit, the PulmonAIR device currently developed is destined to be the first fully automated emergency ventilator for managing respiratory distress.